GlycanAge

GlycanAge, a Newcastle-based life science company, designed a new at-home blood test, MenoAge, which has the potential to diagnose menopause and perimenopause.

Headquartered at The Catalyst on Newcastle’s Helix development, home to the National Innovation Centre for Ageing and a dynamic cluster of life science businesses, industry leaders and academics, GlycanAge benefitted from a close network of sector expertise and a wealth of collaborative opportunities which was the perfect environment for translating research into tangible and impactful products for the healthcare market.

MenoAge is in the process of being recognised by the NHS and the National Institute for Health and Care Excellence and could save the NHS over £500 million by contributing to timely treatment of perimenopause in the UK.